Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionBoston Research & Management Inc
Latest Disclosed Ownership59,676 shares
Latest Disclosed Value $ 6,126
Boston Research & Management Inc reports 5.21% increase in ownership of ABL / Abbott Laboratories

On April 10, 2026 - Boston Research & Management Inc filed a 13F-HR form disclosing ownership of 59,676 shares of Abbott Laboratories (DE:ABL) valued at $5,300,422 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 56,721 shares of Abbott Laboratories. This represents a change in shares of 5.21% during the quarter. The current value of the position is $4,488,829 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F Abbott Laboratories COM 002824100 59,676 2,955 5.21 6 -14.29 1.4552
2026-02-11 2025-12-31 13F Abbott Laboratories COM 002824100 56,721 -2,616 -4.41 7 0.00 1.6385
2025-11-12 2025-09-30 13F Abbott Laboratories COM 002824100 59,337 942 1.61 8 0.00 1.7529
2025-08-12 2025-06-30 13F Abbott Laboratories COM 002824100 58,395 -921 -1.55 8 0.00 1.8983
2025-05-12 2025-03-31 13F Abbott Laboratories COM 002824100 59,316 -3,050 -4.89 8 0.00 1.9538
2025-02-12 2024-12-31 13F Abbott Laboratories COM 002824100 62,366 -24 -0.04 7 0.00 1.7316
2024-11-12 2024-09-30 13F Abbott Laboratories COM 002824100 62,390 465 0.75 7 16.67 1.6710
2024-08-13 2024-06-30 13F Abbott Laboratories COM 002824100 61,925 141 0.23 6 -14.29 1.6269
2024-05-14 2024-03-31 13F Abbott Laboratories COM 002824100 61,784 61 0.10 7 16.67 1.7356
2024-02-12 2023-12-31 13F Abbott Laboratories COM 002824100 61,723 1,340 2.22 7 20.00 1.8035
2023-11-13 2023-09-30 13F Abbott Laboratories COM 002824100 60,383 490 0.82 6 -16.67 1.7285
2023-08-01 2023-06-30 13F Abbott Laboratories COM 002824100 59,893 299 0.50 7 0.00 1.8487
2023-05-10 2023-03-31 13F Abbott Laboratories COM 002824100 59,594 590 1.00 6 0.00 1.8021
2023-02-13 2022-12-31 13F Abbott Laboratories COM 002824100 59,004 -2,140 -3.50 6 -99.90 2.0044
2022-11-14 2022-09-30 13F Abbott Laboratories COM 002824100 61,144 2,415 4.11 5,916 -7.27 2.0155
2022-08-11 2022-06-30 13F Abbott Laboratories COM 002824100 58,729 675 1.16 6,380 -7.15 2.0665
2022-05-12 2022-03-31 13F Abbott Laboratories COM 002824100 58,054 -1,197 -2.02 6,871 -17.59 1.9947
2022-02-10 2021-12-31 13F Abbott Laboratories COM 002824100 59,251 -115 -0.19 8,338 18.91 2.2765
2021-11-10 2021-09-30 13F/A-1 Abbott Laboratories COM 002824100 59,366 420 0.71 7,012 2.62 2.0882
2021-11-10 2021-09-30 13F Abbott Laboratories COM 002824100 56,621 -2,325 6,785 2.1841
2021-08-11 2021-06-30 13F Abbott Laboratories COM 002824100 58,946 2,325 4.11 6,833 0.71 2.0727
2021-05-11 2021-03-31 13F Abbott Laboratories COM 002824100 56,621 -1,050 -1.82 6,785 7.46 2.1841
2021-02-09 2020-12-31 13F Abbott Laboratories COM 002824100 57,671 -196 -0.34 6,314 0.27 2.1966
2020-11-09 2020-09-30 13F Abbott Laboratories COM 002824100 57,867 -2,348 -3.90 6,297 14.39 2.4625
2020-08-10 2020-06-30 13F Abbott Laboratories COM 002824100 60,215 -166 -0.27 5,505 15.55 2.2872
2020-05-08 2020-03-31 13F Abbott Laboratories COM 002824100 60,381 -356 -0.59 4,764 -9.69 2.3918
2020-02-07 2019-12-31 13F Abbott Laboratories COM 002824100 60,737 -250 -0.41 5,275 3.39 1.9788
2019-11-12 2019-09-30 13F Abbott Laboratories COM 002824100 60,987 -915 -1.48 5,102 -1.98 2.0175
2019-08-07 2019-06-30 13F Abbott Laboratories COM 002824100 61,902 -740 -1.18 5,205 3.95 2.1053
2019-05-07 2019-03-31 13F Abbott Laboratories COM 002824100 62,642 -3,010 -4.58 5,007 5.45 2.0862
2019-02-06 2018-12-31 13F Abbott Laboratories COM 002824100 65,652 7,550 12.99 4,748 11.40 2.2608
2018-11-13 2018-09-30 13F Abbott Laboratories COM 002824100 58,102 150 0.26 4,262 20.60 1.9474
2018-07-30 2018-06-30 13F Abbott Laboratories COM 002824100 57,952 -1,140 -1.93 3,534 -0.17 1.7392
2018-05-09 2018-03-31 13F Abbott Laboratories COM 002824100 59,092 590 1.01 3,540 6.05 1.8038
2018-02-09 2017-12-31 13F Abbott Laboratories COM 002824100 58,502 -2,705 -4.42 3,338 2.20 1.6739
2017-11-09 2017-09-30 13F Abbott Laboratories COM 002824100 61,207 295 0.48 3,266 10.34 1.6690
2017-08-08 2017-06-30 13F Abbott Laboratories COM 002824100 60,912 100 0.16 2,960 9.63 1.6013
2017-05-05 2017-03-31 13F Abbott Laboratories COM 002824100 60,812 4,140 7.31 2,700 24.08 1.4709
2017-02-09 2016-12-31 13F Abbott Laboratories COM 002824100 56,672 -6,055 -9.65 2,176 -17.95 1.2379
2016-11-07 2016-09-30 13F Abbott Laboratories COM 002824100 62,727 3,965 6.75 2,652 14.85 1.5320
2016-08-10 2016-06-30 13F Abbott Laboratories COM 002824100 58,762 4,638 8.57 2,309 1.99 1.4000
2016-05-13 2016-03-31 13F Abbott Laboratories COM 002824100 54,124 8,810 19.44 2,264 11.25 1.4098
2016-02-11 2015-12-31 13F Abbott Laboratories COM 002824100 45,314 2,450 5.72 2,035 18.11 1.2653
2015-11-09 2015-09-30 13F Abbott Laboratories COM 002824100 42,864 7,010 19.55 1,723 -2.05 1.1342
2015-07-31 2015-06-30 13F Abbott Laboratories COM 002824100 35,854 250 0.70 1,759 6.67 1.1134
2015-05-11 2015-03-31 13F Abbott Laboratories COM 002824100 35,604 3,710 11.63 1,649 14.91 1.0459
2015-02-11 2014-12-31 13F Abbott Laboratories COM 002824100 31,894 280 0.89 1,435 9.21 0.8994
2014-11-04 2014-09-30 13F Abbott Laboratories COM 002824100 31,614 -40 -0.13 1,314 1.55 0.8835
2014-08-12 2014-06-30 13F Abbott Laboratories COM 002824100 31,654 1,262 4.15 1,294 10.60 0.8944
2014-05-13 2014-03-31 13F Abbott Laboratories COM 002824100 30,392 538 1.80 1,170 2.27 0.8601
2014-02-07 2013-12-31 13F Abbott Laboratories COM 002824100 29,854 3,542 13.46 1,144 31.04 0.8795
2013-11-08 2013-09-30 13F Abbott Laboratories COM 002824100 26,312 3,147 13.59 873 8.04 0.7374
2013-08-13 2013-06-30 13F/A-1 Abbott Laboratories COM 002824100 23,165 23,165 808 0.7183
2013-08-12 2013-06-30 13F Abbott Laboratories COM 002824100 23,165 808 0.7311
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.